THY1 and breast cancer: Here, we describe how the interaction between Thy-1 (CD90) on activated ECs and β3 Integrin on melanoma and breast cancer cells promotes their migration, TEM, and invasion, via a signaling mechanism that involves Ca2+/hemichannel/ATP/P2X7R activation.